All Stories

  1. Epigenetic regulation by HDAC11-driven STAT3 activation promotes pro-inflammatory cytokine production and endothelial dysfunction upon bacterial infection in diabetes

    Article • Cell Communication and Signaling, February 2026, Springer Science + Business Media

    Dr Anna Krasnodembskaya

  2. Fate and function of exogenously administered mesenchymal stromal cells: current insights and future directions

    Article • Cytotherapy, February 2026, Elsevier

    Dr Anna Krasnodembskaya

  3. Bronchial epithelial cell-derived extracellular vesicles drive inflammasome activation and NTHi infection in COPD

    Article • Frontiers in Immunology, January 2026, Frontiers

    Dr Anna Krasnodembskaya

  4. Transplantation of mesenchymal stromal cell-derived mitochondria alleviates endothelial dysfunction in pre-clinical models of acute respiratory distress syndrome

    Article • Stem Cells Translational Medicine, November 2025, Oxford University Press (OUP)

    Dr Anna Krasnodembskaya

  5. Distal lung organoids derived from adult stem cells as novel tools in deciphering mechanisms of lung regeneration, infection, and cancer

    Article • Stem Cells Translational Medicine, September 2025, Oxford University Press (OUP)

    Dr Anna Krasnodembskaya

  6. Human endothelial colony forming cells (ECFCs) require endothelial protein C receptor (EPCR) for cell cycle progression and angiogenic activity

    Article • Angiogenesis, May 2025, Springer Science + Business Media

    Dr Anna Krasnodembskaya

  7. Acute respiratory distress vs healthy lung environments differently affect mesenchymal stromal cell extracellular vesicle miRNAs

    Article • Cytotherapy, May 2025, Elsevier

    Dr Anna Krasnodembskaya

  8. Mesenchymal stromal cells reduce inflammation and improve lung function in a mouse model of cystic fibrosis lung disease

    Article • Scientific Reports, December 2024, Springer Science + Business Media

    Dr Anna Krasnodembskaya

  9. Stem cells, cell therapies, and bioengineering in lung biology and diseases 2023

    Article • AJP Lung Cellular and Molecular Physiology, September 2024, American Physiological Society

    Dr Anna Krasnodembskaya

  10. Human mesenchymal stromal cells inhibitMycobacterium aviumreplication in clinically relevant models of lung infection

    Article • Thorax, March 2024, BMJ

    Dr Anna Krasnodembskaya

  11. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Article • Journal of Extracellular Vesicles, February 2024, Wiley

    Manuel Varas, Dr Ioannis Azoidis, Dr. Asima Bhattacharyya, Dr Mehdi Kabani, Dr Gabriella Pocsfalvi, Andreina Schoeberlein, Daniel Bachurski, Dr André Görgens, Dr. Ann M Wehman, Dr Muhammad Nawaz, Maja Kosanovic, Dr Anna Krasnodembskaya, Olivier Burgy

  12. The MSC-EV-microRNAome: A Perspective on Therapeutic Mechanisms of Action in Sepsis and ARDS

    Article • Cells, January 2024, MDPI AG

    Dr Anna Krasnodembskaya

  13. The role of extracellular vesicles and gap junctions in inter-cellular mitochondrial transfer

    Article • January 2024, Elsevier

    Dr Anna Krasnodembskaya

  14. Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial

    Article • American Review of Respiratory Disease, August 2023, American Thoracic Society

    Professor Ahilanandan Dushianthan, Dr Anna Krasnodembskaya

  15. TERMIS 2023 – European Chapter Manchester Central Conference Centre Manchester, UK March 28–31, 2023

    Article • Tissue Engineering Part A, June 2023, Mary Ann Liebert Inc

    Dr Anna Krasnodembskaya

  16. Nebulised mesenchymal stem cell derived extracellular vesicles ameliorate E. coli induced pneumonia in a rodent model

    Article • Stem Cell Research & Therapy, June 2023, Springer Science + Business Media

    Dr Anna Krasnodembskaya

  17. The Role of Lung Resident Mesenchymal Stromal Cells in the Pathogenesis and Repair of Chronic Lung Disease

    Article • Stem Cells, February 2023, Oxford University Press (OUP)

    Dr Anna Krasnodembskaya

  18. Biomarkers of mitochondrial dysfunction in acute respiratory distress syndrome: A systematic review and meta-analysis

    Article • Frontiers in Medicine, December 2022, Frontiers

    Dr Anna Krasnodembskaya

  19. T4 Novel lung organoid model reveals crucial role of lung resident mesenchymal stromal cells in COPD pathogenesis

    Article • November 2022, BMJ

    Dr Anna Krasnodembskaya

  20. Mesenchymal stromal cells-derived extracellular vesicles reprogramme macrophages in ARDS models through the miR-181a-5p-PTEN-pSTAT5-SOCS1 axis

    Article • Thorax, August 2022, BMJ

    Dr Anna Krasnodembskaya

  21. Novel Antibacterial Properties of the Human Dental Pulp Multipotent Mesenchymal Stromal Cell Secretome

    Article • American Journal Of Pathology, June 2022, Elsevier

    Dr Anna Krasnodembskaya

  22. Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases

    Article • Clinical Microbiology Reviews, December 2021, ASM Journals

    Dr Anna Krasnodembskaya

  23. Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial

    Article • EClinicalMedicine, November 2021, Elsevier

    Dr Anna Krasnodembskaya

  24. Multicomponent Peptide Hydrogels as an Innovative Platform for Cell-Based Tissue Engineering in the Dental Pulp

    Article • Pharmaceutics, September 2021, MDPI AG

    Dr Anna Krasnodembskaya

  25. Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases

    Article • Frontiers in Pharmacology, April 2021, Frontiers

    Dr Anna Krasnodembskaya

  26. Healthy versus inflamed lung environments differentially affect mesenchymal stromal cells

    Article • European Respiratory Journal, April 2021, European Respiratory Society (ERS)

    Dr Anna Krasnodembskaya

  27. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Article • Autophagy, January 2021, Taylor & Francis

    MD, PhD Pierre-Louis Tharaux, Joilson O. Martins, Dr. rer. nat. Marc Herb, Dr Marcia R Cominetti, Alessio Di Fonzo, Christoph Gerhardt, Dr Mustafa Sahin, Dr Cinzia Volonté, Dr Marc Etienne Poirot, Professor Paula I. Moreira, Executive Director, The Hormel Institute Robert Clarke, Prof Robert Bryson-Richardson, Professor Hyun Kyu Song, Prof Claudia Cavadas, Professor Po Sing Leung, Paula Ludovico, Javeed Shah, Prof. Dr. Giovanni Di Guardo, Dr Takeshi Noda, Professor Tullio Florio, Professor Kevin Coombs, Ning Chen, Maria Vaccaro, Dr Jorge F Quarleri, Professor hengyi xiao, Dr. Yanzhuang Wang, Prof Giacinto Bagetta, Dr. Ann M Wehman, Dr Pawan Sharma, Dr Anna Krasnodembskaya, Dr Francesca Finetti, Nicoletta Filigheddu, Professor Javier González-Gallego, Professor Günther Weindl, Professor Nektarios Tavernarakis

  28. Investigation of the MSC Paracrine Effects on Alveolar–Capillary Barrier Integrity in the In Vitro Models of ARDS

    Article • January 2021, Springer Science + Business Media

    Dr Anna Krasnodembskaya

  29. Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS

    Article • European Respiratory Journal, December 2020, European Respiratory Society (ERS)

    Dr Anna Krasnodembskaya

  30. Differential effects of the cystic fibrosis lung inflammatory environment on mesenchymal stromal cells

    Article • AJP Lung Cellular and Molecular Physiology, December 2020, American Physiological Society

    Dr Anna Krasnodembskaya

  31. Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019

    Article • ERJ Open Research, October 2020, European Respiratory Society (ERS)

    Dr Amy L Ryan, Darcy Wagner, Dr Anna Krasnodembskaya

  32. Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2020, Endocrine Society

    Dr Anna Krasnodembskaya

  33. Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome

    Article • European Respiratory Review, June 2020, European Respiratory Society (ERS)

    Dr Anna Krasnodembskaya

  34. Transfer of mitochondria through msc-derived extracellular vesicles improves alveolar-capillary barrier integrity and alleviate mitochondrial dysfunction in acute respiratory distress syndrome (ards)

    Article • Cytotherapy, May 2020, Elsevier

    Dr Anna Krasnodembskaya

  35. In reply

    Article • Stem Cells Translational Medicine, April 2020, Oxford University Press (OUP)

    Dr Anna Krasnodembskaya

  36. Emerging Therapeutic Potential of Mesenchymal Stem/Stromal Cells in Preeclampsia

    Article • Current Hypertension Reports, April 2020, Springer Science + Business Media

    Dr Anna Krasnodembskaya

  37. pSTAT5-SOCS1 signalling as a novel pathway in macrophage metabolic reprogramming by Mesenchymal Stromal Cells (MSCs) in ARDS

    Article • March 2020, European Respiratory Society (ERS)

    Yue Su, Dr Anna Krasnodembskaya

  38. Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome

    Article • Stem Cells Translational Medicine, October 2019, Oxford University Press (OUP)

    Dr Anna Krasnodembskaya

  39. The Necrobiology of Mesenchymal Stromal Cells Affects Therapeutic Efficacy

    Article • Frontiers in Immunology, June 2019, Frontiers

    Dr Anna Krasnodembskaya

  40. Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair

    Article • The FASEB Journal, April 2019, Federation of American Societies For Experimental Biology (FASEB)

    Dr Anna Krasnodembskaya, Lana McClements, Nicola Fergie

  41. Concise Review: Intercellular Communication Via Organelle Transfer in the Biology and Therapeutic Applications of Stem Cells

    Article • Stem Cells, November 2018, Wiley

    Dr Anna Krasnodembskaya

  42. MESENCHYMAL STEM CELLS INFLUENCE TROPHOBLAST AND ENDOTHELIAL CELL FUNCTIONALITY IMPORTANT FOR PREVENTION OF PRE-ECLAMPSIA VIA A NOVEL ANTI-ANGIOGENIC PROTEIN, FKBPL

    Article • Journal of Hypertension, June 2018, Wolters Kluwer Health

    Dr Anna Krasnodembskaya

  43. The TLR4-PAR1 Axis Regulates Bone Marrow Mesenchymal Stromal Cell Survival and Therapeutic Capacity in Experimental Bacterial Pneumonia

    Article • Stem Cells, February 2018, Wiley

    Dr Anna Krasnodembskaya, Victor Nizet

  44. Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer

    Article • American Review of Respiratory Disease, November 2017, American Thoracic Society

    Dr Anna Krasnodembskaya

  45. P47 Hypercapnia impairs the ability of mesenchymal stem cells to promote distal lung epithelial wound repair in ards

    Article • November 2017, BMJ

    Dr Anna Krasnodembskaya

  46. Effects of hypercapnic acidosis on the primary cells relevant to ARDS pathophysiology and the therapeutic potential of mesenchymal stem cells

    Article • September 2017, European Respiratory Society (ERS)

    Dr Anna Krasnodembskaya

  47. Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS

    Article • Thorax, January 2017, BMJ

    Dr Anna Krasnodembskaya

  48. Analysis of Mitochondrial Transfer in Direct Co-cultures of Human Monocyte-derived Macrophages (MDM) and Mesenchymal Stem Cells (MSC)

    Article • BIO-PROTOCOL, January 2017, Bio-Protocol, LLC

    Dr Anna Krasnodembskaya

  49. S80 Mesenchymal stromal cells (MSC) modulate human macrophages in acute respiratory distress syndrome (ARDS) via secretion of extracellular vesicles (EV) which enhance oxidative phosphorylation and regulate jak/stat signalling

    Article • Thorax, November 2016, BMJ

    Dr Anna Krasnodembskaya

  50. Mesenchymal stromal cells (MSC) anti-microbial effect in acute respiratory distress syndrome (ARDS) is mediated in part by enhanced alveolar macrophage phagocytosis through cell contact-dependent mitochondrial transfer leading to improved macrophage bi...

    Article • September 2016, European Respiratory Society (ERS)

    Dr Anna Krasnodembskaya

  51. Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS

    Article • Stem Cells, April 2016, Wiley

    Dr Anna Krasnodembskaya

  52. S63 Human Mesenchymal Stromal Cell (hMSC) regulation of human macrophages inin vitromodels of the Acute Respiratory Distress Syndrome (ARDS)

    Article • Thorax, November 2015, BMJ

    Dr Anna Krasnodembskaya

  53. T3 Mitochondrial transfer is an important mechanism by which Mesenchymal Stromal Cells (MSC) facilitate macrophage phagocytosis in thein vitroandin vivomodels of Acute Respiratory Distress Syndrome (ARDS)

    Article • Thorax, November 2015, BMJ

    Dr Anna Krasnodembskaya

  54. Interaction of arenicin-1 with C1q protein

    Article • Russian Journal of Bioorganic Chemistry, November 2015, Pleiades Publishing Ltd

    Dr Anna Krasnodembskaya

  55. Mesenchymal stromal cells for treatment of the acute respiratory distress syndrome: The beginning of the story

    Article • Journal of the Intensive Care Society, May 2015, SAGE Publications

    Dr Anna Krasnodembskaya

  56. Взаимодействие ареницина-1 с белком C1Q

    Article • Биоорганическая химия, January 2015, Akademizdatcenter Nauka

    Dr Anna Krasnodembskaya

  57. Expression pattern of arenicins—the antimicrobial peptides of polychaete Arenicola marina

    Article • Frontiers in Physiology, December 2014, Frontiers

    Dr Anna Krasnodembskaya

  58. T1 Aspirin reduces pulmonary inflammation in an inhaled lipopolysaccharide model of acute respiratory distress syndrome (ARDS) in healthy volunteers and in a human ex vivo lung perfusion model of ARDS

    Article • Thorax, November 2014, BMJ

    Dr Anna Krasnodembskaya

  59. 0995. Aspirin reduces neutrophilic pulmonary inflammation in a human model of acute respiratory distress syndrome induced by inhaled lipopolysaccharide

    Article • Intensive Care Medicine Experimental, September 2014, Springer Science + Business Media

    Dr Anna Krasnodembskaya

  60. Correction

    Article • Thorax, February 2014, BMJ

    Dr Anna Krasnodembskaya

  61. Therapeutic Effects of Human Mesenchymal Stem Cells inEx VivoHuman Lungs Injured with Live Bacteria

    Article • American Review of Respiratory Disease, April 2013, American Thoracic Society

    Dr Anna Krasnodembskaya

  62. MSCs for Treatment of Acute Lung Injury

    Article • December 2012, Springer Science + Business Media

    Dr Anna Krasnodembskaya

  63. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes

    Article • AJP Lung Cellular and Molecular Physiology, May 2012, American Physiological Society

    Dr Anna Krasnodembskaya

  64. Mouse Mesenchymal Stem Cells Enhance The Innate Respiratory Immune Response To Bacterial Infection By Secretion Of Lipocalin 2 /NGAL

    Article • May 2012, American Thoracic Society

    Dr Anna Krasnodembskaya

  65. Mesenchymal stem cells enhance survival and bacterial clearance in murineEscherichia colipneumonia

    Article • Thorax, January 2012, BMJ

    Dr Anna Krasnodembskaya

  66. Concise Review: Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors

    Article • Stem Cells, May 2011, Wiley

    Dr Anna Krasnodembskaya

  67. Allogeneic Human Mesenchymal Stem Cells Inhibit Bacterial Growth And Restore Normal Alveolar Fluid Transport In An Ex Vivo Perfused Human Lung Injured By Live E. Coli

    Article • May 2011, American Thoracic Society

    Dr Anna Krasnodembskaya

  68. Human Mesenchymal Stem Cells Exert Antimicrobial Activity In Vitro And In Vivo In Part Through The Secretion Of The Antimicrobial Peptide LL-37

    Article • May 2011, American Thoracic Society

    Dr Anna Krasnodembskaya

  69. Mesenchymal Stem Cells Therapy Reduces Bacteremia And Enhances The Phagocytic Activity Of Circulating Monocytes In A Mouse Model Of Gram Negative Sepsis

    Article • May 2011, American Thoracic Society

    Dr Anna Krasnodembskaya

  70. Antibacterial Effect of Human Mesenchymal Stem Cells Is Mediated in Part from Secretion of the Antimicrobial Peptide LL-37

    Article • Stem Cells, December 2010, Wiley

    Dr Anna Krasnodembskaya

  71. Mesenchymal Stem Cells Augment The Innate Respiratory Immune Response To Bacterial Infection And Possess Intrinsic Antimicrobial Properties

    Article • May 2010, American Thoracic Society

    Dr Anna Krasnodembskaya

  72. Bone Marrow-Derived Cells Participate in Stromal Remodeling of the Lung Following Acute Bacterial Pneumonia in Mice

    Article • Lung, March 2008, Springer Science + Business Media

    Dr Anna Krasnodembskaya

  73. Structure and mode of action of the antimicrobial peptide arenicin

    Article • Biochemical Journal, February 2008, Portland Press Ltd.

    Prof. Dr. Torsten Goldmann, Dr Anna Krasnodembskaya

  74. Peroxiredoxin V Contributes to Antioxidant Defense of Lung Epithelial Cells

    Article • Lung, January 2008, Springer Science + Business Media

    Dr Anna Krasnodembskaya

  75. Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaetaArenicola marina

    Article • FEBS Letters, October 2004, Wiley

    Dr Anna Krasnodembskaya